The Multi-Omics hub aims to make omics technologies usable for translational applications. These include the establishment of standardized pipelines for the preparation of samples and data, the development of computer-aided approaches for the integration, analysis and modelling of omics data, the continuous development of omics methods and technologies, as well as omics-based diagnostic analysis and therapeutic approaches.
The hub combines modern high-throughput technologies with bioinformatic methodology for the comprehensive analysis of genes, proteins and metabolic products as well as their interactions and phenotypical characteristics. The focus here is on the analysis of clinical samples using state-of-the-art omics technologies, which not only contribute to a better understanding of pathological mechanisms, but can also be used for the diagnosis and treatment of individual patients. In cooperation with the Clinical Translation hub, omics data can be correlated with external characteristics and clinical parameters, allowing a systems-medical understanding of disease-related mechanisms as well as the diagnostic and therapeutic options.
|Prof. Dr. Nils Blüthgen (spokesman)||Charité|
|Prof. Dr. David Capper||Charité|
|Prof. Dr. Angelika Eggert (spokeswomn)||Charité|
|Dr. Jan Philipp Junker||MDC-BIMSB|
|Dr. Jennifer Kirwan||BIH, MDC|
|Prof. Dr. Marcus Mall||BIH, Charité|
|Dr. Philipp Mertins||BIH, MDC|